Internet filters designed to block pornographic Web sites also prevent users from accessing health information online up to a quarter of the time. Experts say the filters are bad news for teen-agers and low-income people who rely on the Net.
Women and girls in developing countries are likely to benefit most from the new cervical cancer vaccine, but reaching them will be difficult. Also, advocates spar at the final public hearing on Title IX over the “proportionality” rule.
As international officials mark World AIDS Day, researchers are looking for new measures that will help women protect themselves from the deadly disease. One possibility: the diaphragm.
Recent coverage of the merits and risks of hormone-replacement therapy hasn’t answered the question of how the treatment affects sexual desire. Evidence suggests the therapy may dampen a woman’s libido.
The group Priests for Life is warning public schools of potential “legal liability” if the systems’ personnel refer students to health organizations such as Planned Parenthood or permit the organizations to provide sex education.
A whopping 70 percent of American women have uterine fibroids, many of them African American. As the first year of a basic research study is nearing completion, a bill to authorize additional funding for more studies is stalled in Congress.
A first-of-its-kind government study of emergency contraception in New York City finds that nearly half of city pharmacies don’t carry the products. The city’s own sexually transmitted disease clinics don’t offer emergency contraception, either.
An unprecedented United Nations report on violence and health is expected to be a powerful tool for advocates wishing to improve their nations’ responses to domestic and sexual violence with new legislative and health care policies.
Colombian women in relationships they thought were monogamous are the country’s fastest-growing population being infected with HIV. While many have remained quiet, the lack of medical care has compelled others to bring lawsuits.
Scientists, finding more evidence that women and men respond differently to drug trials, are pushing the government to create a permanent, national database of gender-based differences in pharmaceuticals.
This site uses cookies to provide you with a great user experience. By continuing to use this website, you consent to the use of cookies in accordance with our privacy policy.